CRL
Charles River Laboratories International Inc.

914
Mkt Cap
$7.98B
Volume
569,991.00
52W High
$203.01
52W Low
$91.86
PE Ratio
-103.95
CRL Fundamentals
Price
$162.08
Prev Close
$161.64
Open
$162.87
50D MA
$169.00
Beta
1.33
Avg. Volume
1.04M
EPS (Annual)
$0.1994
P/B
2.34
Rev/Employee
$201,491.99
Loading...
Loading...
News
all
press releases
KBC Group NV Sells 74,940 Shares of Charles River Laboratories International, Inc. $CRL
KBC Group NV cut its position in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 98.2% in the second quarter, according to the company in its most recent filing...
MarketBeat·12h ago
News Placeholder
More News
News Placeholder
Charles River Laboratories International (NYSE:CRL) Upgraded to "Buy" at Argus
Argus raised shares of Charles River Laboratories International from a "hold" rating to a "buy" rating in a report on Monday...
MarketBeat·2d ago
News Placeholder
Empower Advisory Group LLC Has $333,000 Stock Holdings in Charles River Laboratories International, Inc. $CRL
Empower Advisory Group LLC decreased its holdings in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 59.9% in the 2nd quarter, according to its most recent 13F...
MarketBeat·3d ago
News Placeholder
Geode Capital Management LLC Has $186.60 Million Stock Position in Charles River Laboratories International, Inc. $CRL
Geode Capital Management LLC lowered its position in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 2.5% in the second quarter, according to the company in its...
MarketBeat·3d ago
News Placeholder
Charles River (CRL) International Revenue Performance Explored
Explore how Charles River's (CRL) revenue from international markets is changing and the resulting impact on Wall Street's predictions and the stock's prospects.
Zacks·3d ago
News Placeholder
Charles River Laboratories to Present at Jefferies Global Healthcare Conference
Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it will present at the Jefferies Global Healthcare Conference in London on Tuesday, November 18th, at 11:30 a.m. GMT...
Business Wire·3d ago
News Placeholder
Banco Bilbao Vizcaya Argentaria S.A. Has $2.15 Million Stake in Charles River Laboratories International, Inc. $CRL
Banco Bilbao Vizcaya Argentaria S.A. lifted its holdings in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 355.3% during the second quarter, according to the...
MarketBeat·4d ago
News Placeholder
Fox Run Management L.L.C. Makes New Investment in Charles River Laboratories International, Inc. $CRL
Fox Run Management L.L.C. bought a new stake in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) during the 2nd quarter, according to its most recent 13F filing with...
MarketBeat·6d ago
News Placeholder
Charles River Laboratories International (NYSE:CRL) Price Target Raised to $185.00 at Morgan Stanley
Morgan Stanley upped their price objective on shares of Charles River Laboratories International from $170.00 to $185.00 and gave the company an "equal weight" rating in a research note on Tuesday...
MarketBeat·8d ago
News Placeholder
Charles River Laboratories International (NYSE:CRL) Given New $197.00 Price Target at TD Cowen
TD Cowen dropped their target price on Charles River Laboratories International from $205.00 to $197.00 and set a "buy" rating for the company in a research report on Monday...
MarketBeat·9d ago

Latest CRL News

View

Advertisement|Remove ads.

Advertisement|Remove ads.